Seroprevalence of immunity to hepatitis A and hepatitis B among gay, bisexual and other men who have sex with men (GBMSM) attending sexual health clinics in London and Leeds, England, 2017–2018
- Published on 05/05/2026
- Reading time: 5 min.
Rachel Roche1,2, Ruth Simmons1,2, Hester Allen1, Megan Glancy1, Anca-Maria Balan3, Maria Bolea3, Ross Harris1,2, Monica Desai1,2, Hamish Mohammed1,2, Caroline Sabin2,4, Samreen Ijaz2,3, Sema Mandal1,2
1Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Division, UK Health Security Agency-Colindale, London, UK
2The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with the UK Health Security Agency, London, UK
3Virus Reference Department, UK Health Security Agency-Colindale, London, UK
4Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, UK
Correspondence to Ms Rachel Roche, Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Division, UK Health Security Agency-Colindale, London, UK; rachel.roche@ukhsa.gov.uk
Abstract
Objectives Although hepatitis A virus (HAV) and hepatitis B virus (HBV) immunisation is recommended in the UK for gay, bisexual and other men who have sex with men (GBMSM), data on immunisation coverage are limited. We aimed to determine the seroprevalence of HAV and HBV immunity among a sample of GBMSM attending sexual health services (SHS) in England.
Methods Residual serum samples from HIV/syphilis testing for adult GBMSM attending eight SHS in London...
To continue reading this article in Full-Text...
Search | Advanced search
Articles by topics
